155 related articles for article (PubMed ID: 36111292)
1. Retrospective analysis of leflunomide and low-dose methylprednisolone for the treatment of diabetic nephropathy combined with membranous nephropathy.
Shang S; Cui S; Wang W; Wang C; Li P; Li W; Li Q
Front Endocrinol (Lausanne); 2022; 13():941215. PubMed ID: 36111292
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy.
Guo Y; Wu X; Liu L; Zhang H; Yang L; Chen W
Ren Fail; 2020 Nov; 42(1):122-130. PubMed ID: 31957527
[No Abstract] [Full Text] [Related]
3. Leflunomide plus oral prednisone in treatment of idiopathic membranous nephropathy: a retrospective clinical study of efficacy and safety.
Yang S; Xie L; Xue W; Yin A; Lu W
Nephrology (Carlton); 2013 Sep; 18(9):615-22. PubMed ID: 23889815
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy.
Shang SL; Cai GY; Duan SW; Li P; Li QG; Chen XM
BMC Nephrol; 2018 Jul; 19(1):182. PubMed ID: 30021637
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of leflunomide in IgA nephropathy: a systematic review and meta-analysis.
Yi J; He Z; Xu S; Feng S
Int Urol Nephrol; 2019 Nov; 51(11):1987-1998. PubMed ID: 31515666
[TBL] [Abstract][Full Text] [Related]
6. Leflunomide plus low-dose prednisone in patients with progressive IgA nephropathy: a multicenter, prospective, randomized, open-labeled, and controlled trial.
Ni Z; Zhang Z; Yu Z; Lu F; Mei C; Ding X; Yuan W; Zhang W; Jiang G; Sun M; He L; Deng Y; Pang H; Qian J
Ren Fail; 2021 Dec; 43(1):1214-1221. PubMed ID: 34396911
[TBL] [Abstract][Full Text] [Related]
7. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
Branten AJ; Wetzels JF
Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
[TBL] [Abstract][Full Text] [Related]
8. Combination of Rituximab, Low-Dose Cyclophosphamide, and Prednisone for Primary Membranous Nephropathy: A Case Series With Extended Follow Up.
Zonozi R; Laliberte K; Huizenga NR; Rosenthal JK; Jeyabalan A; Collins AB; Cortazar FB; Niles JL
Am J Kidney Dis; 2021 Dec; 78(6):793-803. PubMed ID: 34174365
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
Yokoyama H; Sugiyama H; Narita I; Saito T; Yamagata K; Nishio S; Fujimoto S; Mori N; Yuzawa Y; Okuda S; Maruyama S; Sato H; Ueda Y; Makino H; Matsuo S
Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687
[TBL] [Abstract][Full Text] [Related]
10. Renal outcomes of idiopathic and atypical membranous nephropathy in adult Chinese patients: a single center retrospective cohort study.
Jiang Z; Cai M; Dong B; Yan Y; Wang Y; Li X; Shao C; Zuo L
BMC Nephrol; 2021 Apr; 22(1):148. PubMed ID: 33888083
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy and safety of full-dose versus half-dose corticosteroids plus leflunomide for IgA nephropathy.
Li Y; Xiong Y; Huang T; Liu X; Xu G
BMC Nephrol; 2021 Nov; 22(1):364. PubMed ID: 34736419
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
Liang Q; Li H; Xie X; Qu F; Li X; Chen J
Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
[TBL] [Abstract][Full Text] [Related]
13. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.
Ponticelli C; Altieri P; Scolari F; Passerini P; Roccatello D; Cesana B; Melis P; Valzorio B; Sasdelli M; Pasquali S; Pozzi C; Piccoli G; Lupo A; Segagni S; Antonucci F; Dugo M; Minari M; Scalia A; Pedrini L; Pisano G; Grassi C; Farina M; Bellazzi R
J Am Soc Nephrol; 1998 Mar; 9(3):444-50. PubMed ID: 9513907
[TBL] [Abstract][Full Text] [Related]
14. Safety of Rituximab Compared with Steroids and Cyclophosphamide for Idiopathic Membranous Nephropathy.
van den Brand JAJG; Ruggenenti P; Chianca A; Hofstra JM; Perna A; Ruggiero B; Wetzels JFM; Remuzzi G
J Am Soc Nephrol; 2017 Sep; 28(9):2729-2737. PubMed ID: 28487395
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of cyclophosphamide or tacrolimus therapy for idiopathic membranous nephropathy.
Zou H; Jiang F; Xu G
Ren Fail; 2019 Nov; 41(1):673-681. PubMed ID: 31354007
[No Abstract] [Full Text] [Related]
16. Additive effect of leflunomide and glucocorticoids compared with glucocorticoids monotherapy in preventing relapse of IgG4-related disease: A randomized clinical trial.
Wang Y; Zhao Z; Gao D; Wang H; Liao S; Dong C; Luo G; Ji X; Li Y; Wang X; Zhao Y; Li K; Zhang J; Jin J; Zhang Y; Zhu J; Zhang J; Huang F
Semin Arthritis Rheum; 2020 Dec; 50(6):1513-1520. PubMed ID: 32113839
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacy and safety of leflunomide versus mycophenolate mofetil in treating IgG4-related disease: a retrospective cohort study.
Chen Y; Li R; Luo X; Wu T; Li J; Liu Z; Peng Y; Lu H; Peng L; Zhou J; Zhao Y; Zeng X; Fei Y; Zhang W
Clin Rheumatol; 2023 Jul; 42(7):1839-1846. PubMed ID: 36781683
[TBL] [Abstract][Full Text] [Related]
18. Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy.
Min L; Wang Q; Cao L; Zhou W; Yuan J; Zhang M; Che X; Mou S; Fang W; Gu L; Zhu M; Wang L; Yu Z; Qian J; Ni Z
Oncotarget; 2017 Jul; 8(29):48375-48384. PubMed ID: 28415636
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of tacrolimus combined with corticosteroids in patients with idiopathic membranous nephropathy: a systematic review and meta-analysis of randomized controlled trials.
Tian Z; Li Y; Xie Y; Yang Y; Xu J
Int Urol Nephrol; 2022 Oct; 54(10):2555-2566. PubMed ID: 35277831
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS
Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
